PMD Device Solutions AB's quarterly market cap
declined
from Mar. 2024 (€17.18 Mil) to Jun. 2024 (€8.97 Mil) and
declined
from Jun. 2024 (€8.97 Mil) to Sep. 2024 (€7.73 Mil).
PMD Device Solutions AB's annual market cap
declined
from Dec. 2021 (€8.32 Mil) to Dec. 2022 (€3.60 Mil) and
declined
from Dec. 2022 (€3.60 Mil) to Dec. 2023 (€0.00 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. PMD Device Solutions AB's Enterprise Value for Today is €3.83 Mil.
PMD Device Solutions AB (STU:8T00) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
PMD Device Solutions AB Market Cap Related Terms
PMD Device Solutions AB Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, PMD Device Solutions AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PMD Device Solutions AB Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PMD Device Solutions AB's Market Cap distribution charts can be found below:
* The bar in red indicates where PMD Device Solutions AB's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
PMD Device Solutions AB's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PMD Device Solutions AB (STU:8T00) has a Market Cap of €1.39 Mil as of Jul. 07, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on PMD Device Solutions AB and its competitors.
Is PMD Device Solutions AB's Market Cap too high?
PMD Device Solutions AB's current Market Cap is €1.39 Mil. Overall, PMD Device Solutions AB has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does PMD Device Solutions AB's Market Cap compare to ABT and SYK?
PMD Device Solutions AB's Market Cap of €1.39 Mil can be compared against companies in the Medical Devices & Instruments industry. The industry median Market Cap is 121.35. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 121.35, based on 868 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on PMD Device Solutions AB and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 121.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PMD Device Solutions AB's current Market Cap is €1.39 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PMD Device Solutions AB stock overvalued right now?
PMD Device Solutions AB (STU:8T00) has a current Market Cap of €1.39 Mil. The current Market Cap is €1.39 Mil. PMD Device Solutions AB's overall GF Score™ is 4/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For PMD Device Solutions AB (STU:8T00), the current Market Cap is €1.39 Mil as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PMD Device Solutions AB develops and sells medical products for respiratory monitoring in both the hospital and homecare setting. Its primary product is RespiraSense, a solution used for monitoring respiratory rate to detect deterioration of a patient's general condition early and to avoid preventable respiratory failure and adverse patient outcomes. RespiraSense is, to the Company's knowledge, the world's only continuous, motion-tolerant respiratory rate monitor delivering class-leading reliability in measuring respiratory rate. RespiraSense is a novel technology that is commercialised in Europe, the UK, and FDA-cleared in the US.
4GF Score
Get the complete analysis for STU:8T00
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:8T00 has been successfully added to your 
